News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Elizabeth McKenna/X
May 1, 2025, 17:54

Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers

Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a recent article by Birgit Wilding et al. published in Cancer Discovery, adding:

“ICYMI in Cancer Discovery – AACR ahead of today’s big clinical plenary at AACR25 – the preclinical characterization and early clinical proof-of-concept of zongertinib, an irreversible HER2 TKI that spares EGFR signaling and has activity in HER2-driven cancers.”

Elizabeth McKenna

Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers

Authors: Birgit Wilding et al.

Elizabeth McKenna

Learn more about Zongertinib in cancer treatment on OncoDaily.

AACR25 Anke Baum Anna C. Obenauf Annemarie Bruining Birgit Wilding cancer Cancer Discovery Daniel Gerlach Dirk Scharn Fiona Spreitzer Flavio Solca Frans L. Opdam Gintautas Vainorius Irene C. Waizenegger Johannes Popow John V. Heymach Krzysztof Chylinski Lydia Woelflingseder Mark A. Pearson Martin Augsten Masachika Ikegami Neil Gibson Noboru Yamamoto Norbert Kraut OncoDaily Oncology Ralph A. Neumüller Shinji Kohsaka Shunsuke Kondo Sylvia Tilandyová Yukina Shirai Zongertinib
Special Coverage
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Insight
May 1, 2025, 17:30
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Blog
May 1, 2025, 17:29
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Blog
May 1, 2025, 17:15
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Drugs
May 1, 2025, 17:14
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25
Blog
May 1, 2025, 17:09
Aynur Aktas: Our Abstract Has Been Selected for Oral Presentation at MASCC 2025
Insight
May 1, 2025, 17:01
Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma - ECOG-ACRIN Cancer Research Group
Blog
May 1, 2025, 16:54
Phnom Penh Launches Cancer Care Projects to Strengthen Services - City Cancer Challenge
Blog
May 1, 2025, 16:49
SHRO honors three medical students from the University of Siena for completing U.S. research program
Blog
May 1, 2025, 16:46
MedAccess and Elekta Partner to Launch Pay-Per-Use Radiotherapy Model for Cancer Care in LMICs